Structure

InChI Key OWTGMPPCCUSXIP-FNXFGIETSA-J
Smile O=c1ccn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+].[Na+].[Na+]
InChI
InChI=1S/C18H26N4O23P4.4Na/c23-9-1-3-21(17(29)19-9)15-13(27)11(25)7(41-15)5-39-46(31,32)43-48(35,36)45-49(37,38)44-47(33,34)40-6-8-12(26)14(28)16(42-8)22-4-2-10(24)20-18(22)30;;;;/h1-4,7-8,11-16,25-28H,5-6H2,(H,31,32)(H,33,34)(H,35,36)(H,37,38)(H,19,23,29)(H,20,24,30);;;;/q;4*+1/p-4/t7-,8-,11-,12-,13-,14-,15-,16-;;;;/m1..../s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H22N4Na4O23P4
Molecular Weight 878.24
AlogP -4.19
Hydrogen Bond Acceptor 21.0
Hydrogen Bond Donor 10.0
Number of Rotational Bond 14.0
Polar Surface Area 404.45
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 49.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Purinergic receptor P2Y1 agonist Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dry Eye Syndromes 3 D015352 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL1767408
FDA SRS X8T9SBH9LL
PubChem 148196
SureChEMBL SCHEMBL1651092